119 related articles for article (PubMed ID: 15862999)
1. Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity.
Asencio M; Hurtado-Guzmán C; López JJ; Cassels BK; Protais P; Chagraoui A
Bioorg Med Chem; 2005 Jun; 13(11):3699-704. PubMed ID: 15862999
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives.
El Aouad N; Berenguer I; Romero V; Marín P; Serrano A; Andujar S; Suvire F; Bermejo A; Ivorra MD; Enriz RD; Cabedo N; Cortes D
Eur J Med Chem; 2009 Nov; 44(11):4616-21. PubMed ID: 19628309
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
[TBL] [Abstract][Full Text] [Related]
4. Halogenated boldine derivatives with enhanced monoamine receptor selectivity.
Sobarzo-Sánchez EM; Arbaoui J; Protais P; Cassels BK
J Nat Prod; 2000 Apr; 63(4):480-4. PubMed ID: 10785418
[TBL] [Abstract][Full Text] [Related]
5. A possible structural determinant of selectivity of boldine and derivatives for the alpha 1A-adrenoceptor subtype.
Madrero Y; Elorriaga M; Martinez S; Noguera MA; Cassels BK; D'Ocon P; Ivorra MD
Br J Pharmacol; 1996 Dec; 119(8):1563-8. PubMed ID: 8982502
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
[TBL] [Abstract][Full Text] [Related]
7. Further SAR study on 11-O-substituted aporphine analogues: identification of highly potent dopamine D3 receptor ligands.
Ye N; Wu Q; Zhu L; Zheng L; Gao B; Zhen X; Zhang A
Bioorg Med Chem; 2011 Mar; 19(6):1999-2008. PubMed ID: 21334902
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and behavioral effects of boldine and glaucine on dopamine systems.
Asencio M; Delaquerrière B; Cassels BK; Speisky H; Comoy E; Protais P
Pharmacol Biochem Behav; 1999 Jan; 62(1):7-13. PubMed ID: 9972839
[TBL] [Abstract][Full Text] [Related]
9. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
[TBL] [Abstract][Full Text] [Related]
10. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines.
Si YG; Choi YK; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
Bioorg Med Chem Lett; 2009 Jan; 19(1):51-3. PubMed ID: 19058967
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological investigation of novel 2-aminothiazole-privileged aporphines.
Liu Z; Chen X; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2008 Jul; 16(14):6675-81. PubMed ID: 18562201
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines.
Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
Bioorg Med Chem Lett; 2008 Jul; 18(14):3971-3. PubMed ID: 18585036
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part II: Influence of the substitution on the benzyl moiety on the affinity for D2L, D4.2, and 5-HT2A receptors.
Carato P; Graulich A; Jensen N; Roth BL; Liégeois JF
Bioorg Med Chem Lett; 2007 Mar; 17(6):1570-4. PubMed ID: 17251022
[TBL] [Abstract][Full Text] [Related]
15. Antipoliovirus structure-activity relationships of some aporphine alkaloids.
Boustie J; Stigliani JL; Montanha J; Amoros M; Payard M; Girre L
J Nat Prod; 1998 Apr; 61(4):480-4. PubMed ID: 9584402
[TBL] [Abstract][Full Text] [Related]
16. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
Lan H; Durand CJ; Teeter MM; Neve KA
Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
[TBL] [Abstract][Full Text] [Related]
17. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
18. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D(2)-like receptor function is converted from excitatory to inhibitory by thyroxine in the developmental hippocampus.
Oh-Nishi A; Saji M; Furudate SI; Suzuki N
J Neuroendocrinol; 2005 Dec; 17(12):836-45. PubMed ID: 16280031
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S
Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
